In this article
The short version
- MOTS-c is a tiny 16-building-block peptide made from your mitochondria's own DNA.
- Hard exercise raised MOTS-c almost 12-fold in human muscle. Old mice given MOTS-c ran about twice as long.
- Human treatment data are early: one small, 4-week study of a modified version showed better liver and sugar markers.
- MOTS-c isn't FDA-approved. In 2026, regulators moved toward allowing pharmacy compounding under strict conditions.
- The most common side effect reported so far is a mild, short-lived injection-site reaction.
Your muscles make a peptide when you push through a hard workout. In old mice, extra doses of it doubled how long they could run on a treadmill. It's called MOTS-c, and it's why stamina and longevity fans can't stop talking about it.
Here's what MOTS-c is, why people want more of it, what the evidence shows (mostly in animals, with early human data), where it stands with regulators, and what to know about side effects.
What MOTS-c is
Your mitochondria, the tiny engines inside your cells, carry their own small set of DNA. In 2015, researchers found that one stretch of it codes for a 16-building-block peptide. They named it MOTS-c.
That makes it a mitochondria-derived peptide: a message sent from your cells' engines to the rest of the cell. Its main target is skeletal muscle. There, it switches on AMPK, a kind of fuel gauge that tells cells to burn more energy and handle sugar better.
Here's an everyday picture. If your mitochondria are a power plant, MOTS-c is the plant manager calling the factory floor to say, "Use the fuel better."
Why people are interested
- Stamina. It's tied to exercise, and in mice it boosted running capacity.
- Metabolism. In mice, it improved how the body handles sugar and helped prevent weight gain on a high-fat diet.
- Healthy aging. Older mice treated late in life moved better and got stronger.
- It's your body's own signal. People like that MOTS-c is something exercise already makes.
What the studies show in animals
The study that first described MOTS-c, published in Cell Metabolism in 2015, found that in mice it prevented both age-related and high-fat-diet insulin resistance, along with diet-induced obesity.
A 2021 study in Nature Communications went further:
- Old mice ran about twice as long. After two weeks of daily MOTS-c, 22-month-old mice ran about 2 times longer and about 2.16 times farther than untreated old mice.
- Late-life treatment helped. Mice started on MOTS-c three times a week at about 2 years old had better grip strength, stride length, and walking performance.
- Lifespan trended up, but not significantly. Median lifespan was 6.4% longer, a difference the authors said needs bigger studies.
What the evidence shows in people
The same 2021 study looked at 10 healthy young men doing ten one-minute, all-out bike sprints.
That shows exercise raises your own MOTS-c. It doesn't show what injected MOTS-c does in people.
For treatment, the main human data come from CB4211, a modified version of MOTS-c developed by a drug company. In a 4-week, placebo-controlled study of 20 adults with obesity and fatty liver, a daily 25 mg injection:
- Significantly lowered ALT and AST, two markers of liver stress.
- Significantly lowered blood sugar.
- Showed a trend toward lower weight, without a significant change.
- Didn't beat placebo on liver fat, which dropped in both groups.
These were company-reported, early results in a small group. There are no large human trials of MOTS-c for stamina, energy, or aging yet.
Where MOTS-c stands with regulators in late 2026
MOTS-c isn't FDA-approved for any use. But 2026 brought big moves on peptide compounding:
- July 2026: FDA's Pharmacy Compounding Advisory Committee voted to recommend adding MOTS-c and five other peptides to the list of substances pharmacies may compound. The vote is advisory only.
- August 2026: FDA sent warning letters to online sellers of "research use only" peptides that were really being sold for people to inject.
- October 30, 2026: HHS published a draft interim policy that would let pharmacies compound MOTS-c and five other peptides under strict conditions. Those include FDA-registered ingredient sources, a "compounded drug product" label, and reporting of side effects. Comments close November 13, 2026, and the final rule on adding MOTS-c to FDA's compounding list is still pending.
The takeaway: get MOTS-c through a clinician and a licensed pharmacy, never from a "research chemical" website.
MOTS-c side effects
- Injection-site reactions. In the CB4211 study, these were the only side effect seen in more than 1 in 10 people. They were mild to moderate and went away on their own.
- No serious side effects were reported in that 4-week study.
- Long-term effects are unknown, because no long-term human studies exist.
- Banned in sport. MOTS-c is on the World Anti-Doping Agency's prohibited list, so competitive athletes shouldn't use it.
Momentum: MOTS-c with a clinician
Momentum is Nirvanix's compounded MOTS-c injection. A Nirvanix clinician reviews your health history and fitness goals, explains what's known and what isn't, and decides whether it fits. If it's prescribed, a licensed pharmacy prepares it and ships it to you, and your plan can change as you go. The consultation is included.
The bottom line
MOTS-c is a peptide your mitochondria make, and hard exercise ramps it up. In mice, it improved metabolism and helped old animals run about twice as long, while human treatment data are still early. If you're curious, start with a clinician who'll walk you through the evidence and get it from a licensed pharmacy.
Want to know if it fits your goals? Take the two-minute quiz.
Common questions
What does MOTS-c do?
MOTS-c is a peptide your mitochondria make that acts mainly on muscle and helps cells manage fuel. In mice, it improved insulin sensitivity, prevented diet-related weight gain, and helped old mice run longer. People use it hoping for more stamina, better metabolism, and healthy aging.
Is MOTS-c FDA-approved?
No. In July 2026, an FDA advisory committee voted to recommend adding MOTS-c to the list of substances pharmacies may compound, and in October 2026 HHS proposed a draft policy allowing compounding under strict conditions. Neither step is FDA approval, and compounded MOTS-c is not FDA-approved.
Does MOTS-c help with weight loss?
In mice, MOTS-c prevented weight gain on a high-fat diet. In a 4-week human study of a modified version, weight trended down but didn't change significantly. It isn't a proven weight-loss drug in people.
What are the side effects of MOTS-c?
In the human study of a modified version, the only common side effect was a mild to moderate injection-site reaction that went away on its own, with no serious side effects. Long-term effects in people are unknown.
Can MOTS-c replace exercise?
No. Exercise raises your own MOTS-c, along with hundreds of other benefits no single peptide can copy. Think of MOTS-c as something to discuss alongside training, not a replacement for it.
